feed,title,long_url,short_url
SeekingAlpha,GT Biopharma submits IND to FDA for CD33+ leukemia therapy,https://seekingalpha.com/news/4042938,
SeekingAlpha,89bio aligns with regulators on Phase 3 trials for NASH candidate,https://seekingalpha.com/news/4042937,
